Show simple item record

dc.contributor.authorPasetti, M.F.
dc.contributor.authorDouglas, S.D.
dc.contributor.authorPlaeger, S.F.
dc.date.accessioned2019-10-08T19:43:50Z
dc.date.available2019-10-08T19:43:50Z
dc.date.issued2017
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85040071735&doi=10.1128%2fCVI.00276-17&partnerID=40&md5=c68881edeb1ea11bc507364b35690049
dc.identifier.urihttp://hdl.handle.net/10713/11087
dc.description.abstractClinical and Vaccine Immunology (CVI) will merge with the American Society for Microbiology (ASM) open-access journal mSphere in January 2018. We commemorate this transition by exploring the history of CVI and that of its predecessor, Clinical and Diagnostic Laboratory Immunology (CDLI), and by acknowledging their contributors. Research on vaccines, clinical immunology, and clinical diagnostic immunology published through mSphere will be available without restrictions to an ever-larger audience, which will expedite progress in the field. ASM remains committed to supporting its members and the research community by facilitating the dissemination of scientific knowledge in these important areas.en_US
dc.description.urihttps://doi.org/10.1128/CVI.00276-17en_US
dc.language.isoen_USen_US
dc.publisherAmerican Society for Microbiologyen_US
dc.relation.ispartofClinical and Vaccine Immunology
dc.subjectVaccinesen_US
dc.titleThe legacy of CVIen_US
dc.typeArticleen_US
dc.identifier.doi10.1128/CVI.00276-17


This item appears in the following Collection(s)

Show simple item record